What are the clinical manifestations of erythema nodosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Manifestations of Erythema Nodosum

Erythema nodosum presents as raised, tender, red or violet subcutaneous nodules of 1–5 cm in diameter, characteristically located bilaterally on the extensor surfaces of the extremities, particularly the anterior tibial areas. 1

Primary Cutaneous Features

The skin lesions have distinctive characteristics that evolve over time:

  • Nodule appearance: Round or oval, slightly raised, non-ulcerative painful nodules ranging from 1-6 cm in diameter, sometimes coalescing 2
  • Color evolution: Initially bright red, progressing to livid red or purplish within days, and finally exhibiting a yellow or greenish appearance resembling a deep bruise 3
  • Distribution: Symmetrical and bilateral, predominantly on shins, ankles, and knees 1. Can also involve the trunk, upper extremities, thighs, forearms, neck, and arms, though less commonly 1, 2
  • Surface characteristics: Never ulcerate and heal without atrophy or scarring 3

Associated Systemic Manifestations

EN frequently presents with systemic symptoms that may precede or accompany the skin lesions:

  • Arthralgia and arthritis: Occurs in 64-70% of cases, typically involving multiple joints symmetrically, more commonly affecting distal lower extremities 1, 4, 5
  • Constitutional symptoms: Fever (present in 60% of cases), malaise (67%), fatigue, and occasionally chills 1, 4, 5
  • Timing: Usually occurs during times of underlying disease activity, particularly in inflammatory bowel disease 6

Diagnostic Considerations

A firm clinical diagnosis can normally be made based on the characteristic appearance and distribution, with biopsy reserved for atypical cases. 1 When performed, histology reveals non-specific focal panniculitis—specifically a septal panniculitis without vasculitis, with thickened septa infiltrated by inflammatory cells extending to periseptal areas 3.

Important Clinical Pitfalls

The differential diagnosis must exclude metastatic Crohn's disease, which can appear as solitary or multiple nodules, plaques, ulcers, or violaceous perifollicular papules at any site, with non-caseating granulomas on histology 1. This distinction is critical as management differs significantly.

Tissue hypersensitivity is characteristically pronounced at sites of trauma and at sites of specific skin testing 5, which can help distinguish EN from other conditions.

The prevalence of EN in inflammatory bowel disease ranges from 4.2-7.5%, occurring more frequently in Crohn's disease than ulcerative colitis, and is more common among female patients 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.